Peterson S N, Trabalzini L, Brtva T R, Fischer T, Altschuler D L, Martelli P, Lapetina E G, Der C J, White G C
Division of Cell Biology, Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 1996 Nov 22;271(47):29903-8. doi: 10.1074/jbc.271.47.29903.
Although Ras and Rap1 share interaction with common candidate effector proteins, Rap1 lacks the transforming activity exhibited by Ras proteins. It has been speculated that Rap antagonizes Ras transformation through the formation of nonproductive complexes with critical Ras effector targets. To understand further the distinct biological functions of these two closely related proteins, we searched for Rap1b-binding proteins by yeast two-hybrid screening. We identified multiple clones that encode the COOH-terminal sequences of a protein that shares sequence identity with RalGDS and RGL, which we have designated RGL2. A 158-amino acid COOH-terminal fragment of RGL2 (RGL2 C-158) bound to Ras superfamily proteins which shared identical effector domain sequences with Rap1 (Ha-Ras, R-Ras, and TC21). RGL2 C-158 binding was impaired by effector domain mutations in Rap1b and Ha-Ras. Furthermore, RGL2 C-158 bound exclusively to the GTP-, but not the GDP-bound form of Ha-Ras. Finally, coexpression of RGL2 C-158 impaired oncogenic Ras activation of transcription from a Ras-responsive promoter element and focus-forming activity in NIH 3T3 cells. We conclude that RGL2 may be an effector for Ras and/or Rap proteins.
尽管Ras和Rap1与共同的候选效应蛋白存在相互作用,但Rap1缺乏Ras蛋白所表现出的转化活性。据推测,Rap通过与关键的Ras效应靶点形成无活性的复合物来拮抗Ras转化。为了进一步了解这两种密切相关蛋白的独特生物学功能,我们通过酵母双杂交筛选寻找Rap1b结合蛋白。我们鉴定出多个克隆,它们编码一种与RalGDS和RGL具有序列同源性的蛋白的COOH末端序列,我们将其命名为RGL2。RGL2的一个158个氨基酸的COOH末端片段(RGL2 C-158)与Ras超家族蛋白结合,这些蛋白与Rap1(Ha-Ras、R-Ras和TC21)具有相同的效应结构域序列。Rap1b和Ha-Ras中的效应结构域突变会损害RGL2 C-158的结合。此外,RGL2 C-158仅与GTP结合形式的Ha-Ras结合,而不与GDP结合形式的Ha-Ras结合。最后,RGL2 C-158的共表达会损害Ras反应性启动子元件的致癌Ras转录激活以及NIH 3T3细胞中的集落形成活性。我们得出结论,RGL2可能是Ras和/或Rap蛋白的效应物。